二氯-(2,2)-对环芳烷 | 39478-89-2

• 分子结构分类: 有机化合物 - 苯类化合物 - 四氢化萘
• 中文名称: 二氯-(2,2)-对环芳烷
• 英文名称: 5,6,7,8-tetrahydro-6-(methylamino)-1,2-naphthalenediol
• 英文别名: (+/-)-5,6-dihydroxy-2-methylaminotetralin；5,6-dihydroxy-2-methylaminotetralin；6-(methylamino)-5,6,7,8-tetrahydronaphthalene-1,2-diol
• CAS: 39478-89-2
• 化学式: C₁₁H₁₅NO₂
• 分子量: 193.246
• InChiKey: BHDFPNRSDABMPW-UHFFFAOYSA-N

物化性质

• 沸点：
  367.8±42.0 °C(Predicted)
• 密度：
  1.24±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1.5
• 重原子数：
  14
• 可旋转键数：
  1
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.45
• 拓扑面积：
  52.5
• 氢给体数：
  3
• 氢受体数：
  3

文献信息

• Optically active2-aminotetralin derivatives, the processes for the preparation thereof and the therapeutical use of pharmaceutical compositions containing them
  申请人：——

  公开号：US20040102652A1

  公开（公告）日：2004-05-27

  The use of the optically active forms of 5,6-dihydroxy-2-methylaminotetralin and acyl esters thereof as medicaments for cardiovascular diseases a process for the preparation thereof and their use in pharmaceutical compositions.

  将5,6-二羟基-2-甲基氨基四氢萘及其酰基酯的光学活性形式用作心血管疾病药物的使用，以及制备这些药物的过程和它们在药物组合物中的使用。
• Process for preparing compounds containing a hydronaphtalene structure with an unsymmetrically substituted benzene ring
  申请人：Solvias AG

  公开号：EP2098511A1

  公开（公告）日：2009-09-09

  Process for preparing a compound according to formula (I) or (Ia) in a high enantiomeric excess, the process comprising reacting a nucleophile of formula R1NHR2 with a chiral compound of formula (II), in the form of a racemate, wherein R1, R2, X, Y, T and U are defined as above, in the presence of a rhodium-based catalytic system which comprises a chiral diphosphine ligand. New compounds made by that process. Use of that process or those compounds for preparing active pharmaceutical ingredients (APIs).

  制备高对映体过量的公式(I)或(Ia)化合物的过程，包括将公式(II)的手性化合物与公式R1NHR2的亲核试剂反应，其中R1、R2、X、Y、T和U的定义如上所述，以光学异构体的形式存在，存在于以手性双膦配体为基础的铑催化系统中。由该过程制备的新化合物。使用该过程或这些化合物制备活性药物成分(APIs)。
• Process for the manufacture of form I of nolomirole hydrochloride
  申请人：CHIESI FARMACEUTICI S.p.A.

  公开号：EP1384708A1

  公开（公告）日：2004-01-28

  A process for the preparation and isolation of the pharmaceutical chemical compound nolomirole hydrochloride in a highly purified crystalline Form I, as well as pharmaceutical preparations thereof for the treatment of patients suffering of cardiovascular diseases such as congestive heart failure and hypertension are described.

  本文描述了一种制备和分离药用化学物质nolomirole hydrochloride的过程，以高度纯化的结晶形式I，以及用于治疗心血管疾病（如充血性心力衰竭和高血压）患者的药物制剂。
• [EN] A PROCESS FOR THE PREPARATION OF 5,6-DIHYDROXY-2-AMINO-1,2,3,4-TETRAHYDRONAPHTHALENE DERIVATIVES<br/>[FR] PROCEDE DE PREPARATION DE DERIVES 5,6-DIHYDROXY-2-AMINO-1,2,3,4-TETRAHYDRONAPHTALENE
  申请人：CHIESI FARMACEUTICI S.P.A.

  公开号：WO1995029147A1

  公开（公告）日：1995-11-02

  (EN) A process, and variations thereof, for the preparation of 5,6-dihydroxy-2-amino-1,2,3,4-tetrahydronaphthalene derivatives of formula (I), wherein R1, R2, R3 can independently be hydrogen or lower alkyl.(FR) Procédé et ses variantes destinés à la préparation de dérivés 5,6-dihydroxy-2-amino-1,2,3,4-tétrahydronaphtalène de la formule (I) dans laquelle R1, R2 et R3 représentent indépendamment hydrogène ou alcoyle inférieur.

  一种用于制备式(I)的5,6-二羟基-2-氨基-1,2,3,4-四氢萘衍生物的方法及其变体，其中R1、R2、R3可以独立地是氢或较低的烷基。
• [EN] PROCESS FOR PREPARING COMPOUNDS CONTAINING A HYDRONAPHTALENE STRUCTURE WITH AN UNSYMMETRICALLY SUBSTITUTED BENZENE RING<br/>[FR] PROCÉDÉ DE PRÉPARATION DE COMPOSÉS CONTENANT UNE STRUCTURE D'HYDRONAPHTALÈNE AVEC UN NOYAU BENZÉNIQUE SUBSTITUÉ DE FAÇON NON SYMÉTRIQUE
  申请人：SOLVIAS AG

  公开号：WO2009109648A1

  公开（公告）日：2009-09-11

  Process for preparing a compound according to formula (I) or (Ia) in a high enantiomeric excess, Formulae (I), (Ia), the process comprising reacting a nucleophile of formula R1NHR2 with a chiral compound of formula (II), in the form of a racemate, Formula (II), in the presence of a rhodium-based catalytic system which comprises a chiral diphosphine ligand, as well as compounds made by that process and the use of that process or those compounds for preparing active pharmaceutical ingredients (APIs).

  制备高对映体选择性的公式(I)或(Ia)化合物的过程，公式(I)、(Ia)包括反应式为R1NHR2的亲核试剂与形式为外消旋体的手性化合物(II)反应，该反应在铑基催化体系的存在下进行，所述催化体系包括手性二膦配体，以及由该过程制备的化合物和使用该过程或这些化合物制备活性药物成分(APIs)。